Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Harmony Biosciences Holdings Inc (HRMY)

Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript Motley Fool - Thu Feb 22, 2:30PM CST

HRMY earnings call for the period ending December 31, 2023.

HRMY : 28.85 (-1.70%)
Why Harmony Biosciences Stock Got Slammed Today Motley Fool - Tue Jan 2, 5:38PM CST

The commercial-stage company was dinged by a bearish new take from a researcher.

BAC : 38.37 (+1.70%)
HRMY : 28.85 (-1.70%)
Charts, tickers, traders - iStock-884650780
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why Barchart Impact - Wed Nov 29, 2023

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 0.8781 (+2.70%)
CARA : 0.7071 (-3.19%)
CRBP : 37.74 (+0.11%)
HRMY : 28.85 (-1.70%)
JAZZ : 109.67 (+0.77%)
Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript Motley Fool - Tue Oct 31, 2023

HRMY earnings call for the period ending September 30, 2023.

HRMY : 28.85 (-1.70%)
HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL RESULTS ON OCTOBER 31, 2023 PR Newswire - Tue Oct 17, 2023

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 28.85 (-1.70%)
Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall, Friday, 10/13/2023 Associated Press - Fri Oct 13, 2023

Stocks that traded heavily or had substantial price changes on Friday: Wells Fargo, JPMorgan Chase rise; Harmony Biosciences, Belden fall

WFC : 60.94 (-0.26%)
HRMY : 28.85 (-1.70%)
C : 62.67 (+2.82%)
CMTL : 1.5800 (-10.23%)
DG : 142.73 (-0.08%)
UNH : 486.18 (-1.03%)
JPM : 192.14 (+1.44%)
Why Shares of Harmony Bioscience Are Falling on Friday Motley Fool - Fri Oct 13, 2023

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

ZYNE : 1.3000 (+2.36%)
HRMY : 28.85 (-1.70%)
HARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3 INTUNE STUDY EVALUATING PITOLISANT IN PATIENTS WITH IDIOPATHIC HYPERSOMNIA PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 28.85 (-1.70%)
HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME PR Newswire - Thu Oct 5, 2023

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...

HRMY : 28.85 (-1.70%)
2 Magnificent Growth Stocks to Buy Right Now Motley Fool - Wed Oct 4, 2023

These two biotech stocks could be big winners for patient investors.

MRK : 126.88 (-0.05%)
PFE : 26.32 (+0.23%)
NVO : 128.64 (+2.70%)
GOOG : 159.92 (+1.25%)
DNA : 0.8705 (+3.29%)
HRMY : 28.85 (-1.70%)

Barchart Exclusives

3 Overlooked Stocks to Buy This Spring Barchart - Tue Apr 23, 3:45PM CDT
With mid-cap stocks anticipated to make a comeback on accelerated earnings growth, here are three overlooked stocks that investors might consider this spring. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot